To evaluate the effect of QSYQ on the development of atherosclerosis, we treated 8w male ApoE-/- mice with a low dose (human equivalent) or high dose (five times of human equivalent) QSYQ for 8 weeks. The gene discussed is APOE; the disease is atherosclerosis.